Tysabri May Be Linked to Melanoma
Feb. 6, 2008 -- Two multiple sclerosis patients developed malignant melanoma -- a deadly form of skin cancer -- soon after starting treatment with Tysabri.
Tysabri slows the self-destructive immune responses that attack the nervous systems of people with MS. In animal studies, these same immune responses hold melanoma in check. Might the drug have caused melanoma in these two MS patients? >>>More



